Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gold | 31 | 2020 | 130 | 8.600 |
Why?
|
Metal Nanoparticles | 27 | 2020 | 130 | 8.520 |
Why?
|
Ovarian Neoplasms | 21 | 2020 | 589 | 4.700 |
Why?
|
Nanoparticles | 11 | 2021 | 287 | 3.380 |
Why?
|
Pancreatic Neoplasms | 13 | 2021 | 540 | 2.970 |
Why?
|
Antineoplastic Agents | 16 | 2021 | 679 | 2.580 |
Why?
|
Cystathionine beta-Synthase | 6 | 2020 | 31 | 2.420 |
Why?
|
Tumor Microenvironment | 6 | 2021 | 177 | 2.360 |
Why?
|
Nanoconjugates | 6 | 2020 | 18 | 2.330 |
Why?
|
Cell Line, Tumor | 36 | 2021 | 1319 | 2.320 |
Why?
|
Nanotechnology | 8 | 2020 | 68 | 1.990 |
Why?
|
Drug Delivery Systems | 10 | 2021 | 225 | 1.980 |
Why?
|
Nanomedicine | 7 | 2019 | 62 | 1.870 |
Why?
|
Mitochondria | 7 | 2020 | 369 | 1.800 |
Why?
|
Cation Transport Proteins | 3 | 2020 | 60 | 1.580 |
Why?
|
Neoplasm Proteins | 4 | 2019 | 123 | 1.510 |
Why?
|
Antibodies, Monoclonal | 5 | 2011 | 329 | 1.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2020 | 465 | 1.240 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2017 | 167 | 1.210 |
Why?
|
Humans | 61 | 2021 | 28094 | 1.200 |
Why?
|
Mitochondrial Membrane Transport Proteins | 3 | 2020 | 23 | 1.140 |
Why?
|
Calcium-Binding Proteins | 3 | 2020 | 62 | 1.120 |
Why?
|
Neovascularization, Pathologic | 6 | 2019 | 149 | 1.070 |
Why?
|
Cell Proliferation | 20 | 2021 | 806 | 1.050 |
Why?
|
Polycomb Repressive Complex 1 | 9 | 2018 | 34 | 1.020 |
Why?
|
Drug Carriers | 5 | 2020 | 115 | 0.960 |
Why?
|
Animals | 33 | 2021 | 10415 | 0.920 |
Why?
|
Pinocytosis | 2 | 2021 | 17 | 0.870 |
Why?
|
MicroRNAs | 3 | 2020 | 301 | 0.860 |
Why?
|
Vascular Endothelial Growth Factor A | 7 | 2021 | 179 | 0.840 |
Why?
|
Hydrogen Sulfide | 3 | 2020 | 32 | 0.810 |
Why?
|
Mice, Nude | 12 | 2021 | 331 | 0.810 |
Why?
|
Oxidative Stress | 4 | 2020 | 668 | 0.780 |
Why?
|
Cisplatin | 5 | 2017 | 179 | 0.770 |
Why?
|
Phototherapy | 2 | 2021 | 28 | 0.750 |
Why?
|
Signal Transduction | 9 | 2020 | 1435 | 0.750 |
Why?
|
Neoplasms | 4 | 2011 | 808 | 0.740 |
Why?
|
Gene Silencing | 4 | 2020 | 65 | 0.740 |
Why?
|
Clathrin | 1 | 2021 | 20 | 0.740 |
Why?
|
Glycolysis | 3 | 2020 | 85 | 0.730 |
Why?
|
Endothelium, Vascular | 4 | 2020 | 325 | 0.720 |
Why?
|
Mitochondrial Dynamics | 1 | 2020 | 12 | 0.680 |
Why?
|
Mice | 21 | 2021 | 4650 | 0.680 |
Why?
|
Protein Corona | 1 | 2020 | 9 | 0.670 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 63 | 0.670 |
Why?
|
Proto-Oncogene Proteins | 4 | 2017 | 140 | 0.650 |
Why?
|
Cancer-Associated Fibroblasts | 1 | 2019 | 10 | 0.640 |
Why?
|
Female | 26 | 2021 | 15153 | 0.630 |
Why?
|
Tissue Distribution | 3 | 2014 | 137 | 0.620 |
Why?
|
Carrier Proteins | 1 | 2020 | 252 | 0.600 |
Why?
|
ErbB Receptors | 5 | 2011 | 100 | 0.600 |
Why?
|
Apoptosis | 11 | 2018 | 775 | 0.590 |
Why?
|
Mitochondrial Proteins | 1 | 2018 | 74 | 0.560 |
Why?
|
Angiogenesis Inhibitors | 2 | 2011 | 109 | 0.560 |
Why?
|
Endocytosis | 4 | 2021 | 89 | 0.550 |
Why?
|
Platinum | 3 | 2012 | 18 | 0.550 |
Why?
|
Silver | 3 | 2012 | 21 | 0.550 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2016 | 115 | 0.530 |
Why?
|
Cetuximab | 6 | 2020 | 21 | 0.530 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 95 | 0.530 |
Why?
|
Pharmaceutical Preparations | 2 | 2014 | 46 | 0.520 |
Why?
|
Lipogenesis | 1 | 2015 | 29 | 0.490 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2016 | 66 | 0.490 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 5 | 2021 | 56 | 0.490 |
Why?
|
Triglycerides | 1 | 2015 | 121 | 0.480 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 138 | 0.460 |
Why?
|
Microscopy, Electron, Transmission | 6 | 2013 | 82 | 0.460 |
Why?
|
Particle Size | 6 | 2021 | 101 | 0.450 |
Why?
|
Cholesterol | 1 | 2015 | 201 | 0.440 |
Why?
|
Cell Movement | 8 | 2019 | 373 | 0.440 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 2011 | 29 | 0.420 |
Why?
|
Designer Drugs | 1 | 2013 | 2 | 0.420 |
Why?
|
Deoxycytidine | 4 | 2020 | 65 | 0.410 |
Why?
|
Proteins | 2 | 2020 | 252 | 0.390 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 162 | 0.390 |
Why?
|
Nuclear Proteins | 3 | 2016 | 247 | 0.390 |
Why?
|
Repressor Proteins | 2 | 2011 | 118 | 0.390 |
Why?
|
Coated Materials, Biocompatible | 1 | 2012 | 24 | 0.380 |
Why?
|
Adenocarcinoma | 3 | 2013 | 298 | 0.380 |
Why?
|
Calcium | 5 | 2017 | 235 | 0.370 |
Why?
|
Drug Design | 1 | 2011 | 63 | 0.360 |
Why?
|
Surface Properties | 4 | 2014 | 134 | 0.360 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2018 | 269 | 0.360 |
Why?
|
Biological Transport | 3 | 2021 | 122 | 0.350 |
Why?
|
Materials Testing | 2 | 2021 | 89 | 0.340 |
Why?
|
Disease | 2 | 2020 | 15 | 0.340 |
Why?
|
Antibodies, Monoclonal, Humanized | 5 | 2011 | 144 | 0.330 |
Why?
|
Phenotype | 4 | 2017 | 680 | 0.330 |
Why?
|
Immunohistochemistry | 4 | 2018 | 463 | 0.320 |
Why?
|
Cell Membrane | 2 | 2010 | 259 | 0.310 |
Why?
|
Veratrum Alkaloids | 1 | 2008 | 4 | 0.310 |
Why?
|
Hedgehog Proteins | 1 | 2008 | 33 | 0.300 |
Why?
|
Pancreatic Stellate Cells | 2 | 2020 | 6 | 0.300 |
Why?
|
Cell Line | 5 | 2018 | 696 | 0.290 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 315 | 0.290 |
Why?
|
Transfection | 4 | 2015 | 318 | 0.280 |
Why?
|
Nanostructures | 1 | 2008 | 64 | 0.280 |
Why?
|
Cells, Cultured | 6 | 2020 | 985 | 0.280 |
Why?
|
Disease Models, Animal | 5 | 2018 | 1459 | 0.270 |
Why?
|
Endoplasmic Reticulum | 2 | 2020 | 80 | 0.270 |
Why?
|
Gene Knockdown Techniques | 4 | 2016 | 134 | 0.260 |
Why?
|
Transcription, Genetic | 2 | 2019 | 403 | 0.250 |
Why?
|
Cell Survival | 4 | 2021 | 409 | 0.250 |
Why?
|
Down-Regulation | 2 | 2018 | 199 | 0.250 |
Why?
|
RNA, Small Interfering | 2 | 2020 | 198 | 0.250 |
Why?
|
Models, Biological | 5 | 2020 | 466 | 0.240 |
Why?
|
Light | 2 | 2014 | 118 | 0.210 |
Why?
|
Microscopy, Confocal | 3 | 2013 | 113 | 0.200 |
Why?
|
Biomarkers, Tumor | 2 | 2016 | 404 | 0.200 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2020 | 60 | 0.200 |
Why?
|
Heterografts | 3 | 2018 | 66 | 0.190 |
Why?
|
Static Electricity | 2 | 2013 | 35 | 0.190 |
Why?
|
Blotting, Western | 4 | 2013 | 514 | 0.190 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 40 | 0.190 |
Why?
|
Gene Expression | 2 | 2013 | 417 | 0.190 |
Why?
|
Reactive Oxygen Species | 3 | 2018 | 285 | 0.180 |
Why?
|
Physiological Phenomena | 1 | 2020 | 2 | 0.180 |
Why?
|
Photoacoustic Techniques | 1 | 2021 | 17 | 0.180 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2020 | 14 | 0.180 |
Why?
|
Endothelial Cells | 2 | 2019 | 352 | 0.170 |
Why?
|
Lysophospholipids | 2 | 2018 | 48 | 0.170 |
Why?
|
Kinetics | 2 | 2020 | 545 | 0.170 |
Why?
|
Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2020 | 6 | 0.170 |
Why?
|
Skin | 1 | 2021 | 149 | 0.170 |
Why?
|
Biosensing Techniques | 1 | 2021 | 43 | 0.170 |
Why?
|
Protein Domains | 1 | 2020 | 52 | 0.170 |
Why?
|
Enzyme Activation | 1 | 2020 | 267 | 0.170 |
Why?
|
Sulfurtransferases | 1 | 2019 | 3 | 0.170 |
Why?
|
Cystathionine gamma-Lyase | 1 | 2019 | 7 | 0.170 |
Why?
|
Protein Binding | 5 | 2017 | 658 | 0.160 |
Why?
|
Immunomodulation | 1 | 2019 | 20 | 0.160 |
Why?
|
Autophagy | 2 | 2020 | 73 | 0.160 |
Why?
|
Sepsis | 1 | 2020 | 84 | 0.160 |
Why?
|
Precision Medicine | 1 | 2020 | 76 | 0.160 |
Why?
|
Liposomes | 1 | 2020 | 145 | 0.160 |
Why?
|
Peptides | 1 | 2021 | 288 | 0.160 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2021 | 103 | 0.160 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 101 | 0.160 |
Why?
|
Phosphorylation | 4 | 2019 | 578 | 0.150 |
Why?
|
DNA Damage | 1 | 2019 | 151 | 0.150 |
Why?
|
Dynamin II | 2 | 2010 | 13 | 0.150 |
Why?
|
Neoplasm Grading | 2 | 2018 | 104 | 0.140 |
Why?
|
Pyrazines | 1 | 2017 | 24 | 0.140 |
Why?
|
Benzimidazoles | 1 | 2017 | 32 | 0.140 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2017 | 19 | 0.140 |
Why?
|
Oxidative Phosphorylation | 1 | 2017 | 29 | 0.140 |
Why?
|
Tumor Burden | 2 | 2016 | 110 | 0.140 |
Why?
|
Microarray Analysis | 1 | 2017 | 64 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 281 | 0.140 |
Why?
|
Adenosine Triphosphate | 2 | 2016 | 118 | 0.140 |
Why?
|
Neovascularization, Physiologic | 2 | 2015 | 124 | 0.140 |
Why?
|
Carbocyanines | 2 | 2021 | 10 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2018 | 478 | 0.130 |
Why?
|
Endometrial Neoplasms | 1 | 2018 | 189 | 0.130 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 15 | 0.130 |
Why?
|
Drug Resistance, Multiple | 1 | 2016 | 20 | 0.130 |
Why?
|
Male | 5 | 2014 | 13489 | 0.130 |
Why?
|
Silicon Dioxide | 2 | 2021 | 43 | 0.130 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2015 | 3 | 0.130 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2015 | 17 | 0.120 |
Why?
|
Sp1 Transcription Factor | 1 | 2015 | 17 | 0.120 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2016 | 32 | 0.120 |
Why?
|
Homeostasis | 1 | 2016 | 118 | 0.120 |
Why?
|
RNA Interference | 1 | 2015 | 137 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 163 | 0.120 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 190 | 0.120 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2015 | 94 | 0.120 |
Why?
|
Cytoprotection | 1 | 2014 | 24 | 0.120 |
Why?
|
Spectrophotometry, Ultraviolet | 2 | 2011 | 54 | 0.110 |
Why?
|
Half-Life | 1 | 2014 | 34 | 0.110 |
Why?
|
Genotype | 1 | 2015 | 456 | 0.110 |
Why?
|
Drug Synergism | 1 | 2014 | 104 | 0.110 |
Why?
|
Area Under Curve | 1 | 2014 | 95 | 0.110 |
Why?
|
Cell Differentiation | 1 | 2016 | 407 | 0.110 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 208 | 0.110 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2013 | 25 | 0.100 |
Why?
|
Neoplasms, Experimental | 2 | 2021 | 58 | 0.100 |
Why?
|
Docosahexaenoic Acids | 1 | 2014 | 105 | 0.100 |
Why?
|
Cadherins | 1 | 2013 | 24 | 0.100 |
Why?
|
Snail Family Transcription Factors | 1 | 2013 | 10 | 0.100 |
Why?
|
Vimentin | 1 | 2013 | 28 | 0.100 |
Why?
|
Body Fluids | 1 | 2013 | 18 | 0.100 |
Why?
|
Scattering, Radiation | 1 | 2013 | 29 | 0.100 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2014 | 126 | 0.100 |
Why?
|
Mutation | 3 | 2017 | 845 | 0.100 |
Why?
|
Computational Biology | 1 | 2014 | 155 | 0.100 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2013 | 39 | 0.100 |
Why?
|
Necrosis | 2 | 2016 | 85 | 0.100 |
Why?
|
Aged, 80 and over | 2 | 2018 | 2021 | 0.100 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 133 | 0.100 |
Why?
|
Models, Molecular | 1 | 2014 | 452 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 607 | 0.100 |
Why?
|
Endosomes | 2 | 2010 | 45 | 0.100 |
Why?
|
Proteomics | 1 | 2014 | 181 | 0.100 |
Why?
|
Antimalarials | 1 | 2012 | 25 | 0.100 |
Why?
|
Antibodies, Immobilized | 1 | 2011 | 4 | 0.090 |
Why?
|
Disease Progression | 1 | 2013 | 473 | 0.090 |
Why?
|
Antioxidants | 1 | 2013 | 223 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 135 | 0.090 |
Why?
|
Folate Receptor 1 | 1 | 2011 | 13 | 0.090 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2009 | 48 | 0.090 |
Why?
|
Molecular Structure | 1 | 2012 | 243 | 0.090 |
Why?
|
Ligands | 1 | 2011 | 176 | 0.090 |
Why?
|
Prognosis | 3 | 2020 | 802 | 0.090 |
Why?
|
Carboplatin | 1 | 2011 | 111 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 328 | 0.090 |
Why?
|
Golgi Apparatus | 1 | 2010 | 26 | 0.090 |
Why?
|
Membrane Potentials | 1 | 2010 | 62 | 0.090 |
Why?
|
Protein Conformation | 1 | 2011 | 257 | 0.080 |
Why?
|
Lysosomes | 1 | 2010 | 56 | 0.080 |
Why?
|
Cell Growth Processes | 1 | 2009 | 18 | 0.080 |
Why?
|
3' Untranslated Regions | 1 | 2009 | 34 | 0.080 |
Why?
|
Surface Plasmon Resonance | 1 | 2009 | 37 | 0.080 |
Why?
|
Sonication | 1 | 2009 | 1 | 0.080 |
Why?
|
Time Factors | 2 | 2011 | 1591 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2010 | 152 | 0.080 |
Why?
|
Serum Albumin, Bovine | 1 | 2009 | 22 | 0.080 |
Why?
|
Transcription Factors | 1 | 2013 | 520 | 0.080 |
Why?
|
Salts | 1 | 2008 | 12 | 0.080 |
Why?
|
Umbilical Veins | 2 | 2005 | 25 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2009 | 77 | 0.080 |
Why?
|
Radio Waves | 1 | 2008 | 21 | 0.070 |
Why?
|
Aged | 2 | 2018 | 5400 | 0.070 |
Why?
|
Terbium | 1 | 2007 | 2 | 0.070 |
Why?
|
Europium | 1 | 2007 | 3 | 0.070 |
Why?
|
Histones | 2 | 2019 | 93 | 0.070 |
Why?
|
Nanotubes | 1 | 2007 | 15 | 0.070 |
Why?
|
Phosphates | 1 | 2007 | 32 | 0.070 |
Why?
|
Hyperthermia, Induced | 1 | 2008 | 30 | 0.070 |
Why?
|
Caspases | 2 | 2018 | 43 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 92 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2008 | 365 | 0.070 |
Why?
|
Treatment Outcome | 1 | 2013 | 2377 | 0.060 |
Why?
|
Middle Aged | 2 | 2018 | 7137 | 0.060 |
Why?
|
Young Adult | 1 | 2013 | 2732 | 0.060 |
Why?
|
Adult | 2 | 2018 | 7739 | 0.060 |
Why?
|
Intracellular Space | 1 | 2005 | 12 | 0.060 |
Why?
|
NIH 3T3 Cells | 1 | 2005 | 44 | 0.060 |
Why?
|
Neoplasm Transplantation | 1 | 2005 | 90 | 0.060 |
Why?
|
Mice, Inbred C3H | 1 | 2005 | 74 | 0.060 |
Why?
|
Trans-Activators | 1 | 2005 | 118 | 0.060 |
Why?
|
Risk Factors | 2 | 2020 | 2081 | 0.060 |
Why?
|
Glutathione | 2 | 2015 | 76 | 0.050 |
Why?
|
Mice, Hairless | 1 | 2021 | 1 | 0.050 |
Why?
|
Sunburn | 1 | 2021 | 2 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2021 | 16 | 0.050 |
Why?
|
Ferric Compounds | 1 | 2021 | 43 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2016 | 138 | 0.040 |
Why?
|
Contrast Media | 1 | 2021 | 96 | 0.040 |
Why?
|
Histone Deacetylase 1 | 1 | 2019 | 10 | 0.040 |
Why?
|
Histone Deacetylase 2 | 1 | 2019 | 10 | 0.040 |
Why?
|
Immunotherapy | 1 | 2021 | 160 | 0.040 |
Why?
|
Editorial Policies | 1 | 2019 | 7 | 0.040 |
Why?
|
Hypoxia | 1 | 2020 | 89 | 0.040 |
Why?
|
Zebrafish | 1 | 2020 | 96 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2020 | 174 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2019 | 53 | 0.040 |
Why?
|
Research | 1 | 2019 | 92 | 0.040 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2018 | 18 | 0.040 |
Why?
|
Hexokinase | 1 | 2018 | 16 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2018 | 35 | 0.040 |
Why?
|
NADPH Oxidases | 1 | 2018 | 69 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 77 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 5 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2017 | 17 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2016 | 12 | 0.030 |
Why?
|
Proteolysis | 1 | 2017 | 58 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2019 | 769 | 0.030 |
Why?
|
Lysine Acetyltransferase 5 | 1 | 2016 | 4 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 37 | 0.030 |
Why?
|
Alarmins | 1 | 2016 | 3 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 23 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 22 | 0.030 |
Why?
|
Heterocyclic Compounds, 2-Ring | 1 | 2016 | 3 | 0.030 |
Why?
|
Doxorubicin | 1 | 2016 | 77 | 0.030 |
Why?
|
Neuropilins | 1 | 2015 | 4 | 0.030 |
Why?
|
Second Messenger Systems | 1 | 2015 | 13 | 0.030 |
Why?
|
Thiazoles | 1 | 2016 | 51 | 0.030 |
Why?
|
Paclitaxel | 1 | 2016 | 190 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 141 | 0.030 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2015 | 65 | 0.030 |
Why?
|
Survival Rate | 1 | 2016 | 430 | 0.030 |
Why?
|
Retinaldehyde | 1 | 2014 | 7 | 0.030 |
Why?
|
Diterpenes | 1 | 2014 | 19 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 343 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2016 | 248 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2016 | 848 | 0.030 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 2010 | 6 | 0.020 |
Why?
|
Nitric Oxide Donors | 1 | 2010 | 11 | 0.020 |
Why?
|
Hepatic Stellate Cells | 1 | 2010 | 14 | 0.020 |
Why?
|
Diffusion | 1 | 2009 | 39 | 0.020 |
Why?
|
Drug Compounding | 1 | 2009 | 30 | 0.020 |
Why?
|
Microspheres | 1 | 2009 | 49 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2009 | 193 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2008 | 21 | 0.020 |
Why?
|
Biomedical Research | 1 | 2007 | 97 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2005 | 19 | 0.020 |
Why?
|
Rats | 1 | 2009 | 1576 | 0.020 |
Why?
|
Guanosine Triphosphate | 1 | 2005 | 29 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2005 | 13 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 29 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2005 | 26 | 0.020 |
Why?
|
Cell Separation | 1 | 2005 | 55 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 68 | 0.020 |
Why?
|
Vesicular Transport Proteins | 1 | 2005 | 34 | 0.020 |
Why?
|
Adenoviridae | 1 | 2005 | 67 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 101 | 0.010 |
Why?
|
Caveolin 1 | 1 | 2005 | 43 | 0.010 |
Why?
|
Cell Cycle | 1 | 2005 | 161 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 163 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 128 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 288 | 0.010 |
Why?
|
Thrombosis | 1 | 2005 | 149 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 447 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2005 | 484 | 0.010 |
Why?
|
Inflammation | 1 | 2005 | 636 | 0.010 |
Why?
|